The relationship between metabolic dysfunction-associated fatty liver disease and low muscle mass in an asymptomatic Korean population.
Ji Yeon SeoEun Ju ChoMin Joo KimMin-Sun KwakJong In YangSu Jin ChungJeong Yoon YimJi Won YoonGoh-Eun ChungPublished in: Journal of cachexia, sarcopenia and muscle (2022)
The presence of MAFLD is significantly associated with increased risk of low muscle mass with varying risks according to the MAFLD subgroups. Clinicians should be aware of the differentiated risk of low muscle mass across the subgroups of MAFLD.